These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27938507)

  • 1. Overexpression of Forkhead Box L1 (FOXL1) Inhibits the Proliferation and Invasion of Breast Cancer Cells.
    Zhong J; Wang H; Yu J; Zhang J; Wang H
    Oncol Res; 2017 Jul; 25(6):959-965. PubMed ID: 27938507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forkhead box L1 is frequently downregulated in gallbladder cancer and inhibits cell growth through apoptosis induction by mitochondrial dysfunction.
    Qin Y; Gong W; Zhang M; Wang J; Tang Z; Quan Z
    PLoS One; 2014; 9(7):e102084. PubMed ID: 25010679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of FOXS1 in gastric cancer cell lines inhibits proliferation, metastasis, and epithelial-mesenchymal transition of tumor through downregulating wnt/β-catenin pathway.
    Lu Q; Ma X; Li Y; Song W; Zhang L; Shu Y; Wan B
    J Cell Biochem; 2019 Mar; 120(3):2897-2907. PubMed ID: 30500980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
    Wang YG; Wang T; Shi M; Zhai B
    J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of forkhead box L1 gene on osteosarcoma growth through the induction of cell cycle arrest and apoptosis.
    Chen X; Deng M; Ma L; Zhou J; Xiao Y; Zhou X; Zhang C; Wu M
    Oncol Rep; 2015 Jul; 34(1):265-71. PubMed ID: 26062977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXL1, a novel candidate tumor suppressor, inhibits tumor aggressiveness and predicts outcome in human pancreatic cancer.
    Zhang G; He P; Gaedcke J; Ghadimi BM; Ried T; Yfantis HG; Lee DH; Hanna N; Alexander HR; Hussain SP
    Cancer Res; 2013 Sep; 73(17):5416-25. PubMed ID: 23801748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression of FOXL1 and PP2A inhibits proliferation inducing apoptosis in pancreatic cancer cells via promoting TRAIL and reducing phosphorylated MYC.
    Li Y; Yu D; Sheng W; Song H; Li Y; Dong M
    Oncol Rep; 2016 Apr; 35(4):2198-206. PubMed ID: 26820810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of FOXK1 Suppresses Proliferation, Migration, and Invasion in Prostate Cancer Cells.
    Chen F; Xiong W; Dou K; Ran Q
    Oncol Res; 2017 Sep; 25(8):1261-1267. PubMed ID: 28267429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-19a-3p regulates the Forkhead box F2-mediated Wnt/β-catenin signaling pathway and affects the biological functions of colorectal cancer cells.
    Yu FB; Sheng J; Yu JM; Liu JH; Qin XX; Mou B
    World J Gastroenterol; 2020 Feb; 26(6):627-644. PubMed ID: 32103872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway.
    Yang S; Li X; Shen W; Hu H; Li C; Han G
    J Surg Res; 2021 Jan; 257():267-277. PubMed ID: 32862055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
    Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
    Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Necrosis Factor (TNF)-α-Induced Protein 8-like-2 (TIPE2) Inhibits Proliferation and Tumorigenesis in Breast Cancer Cells.
    Wang K; Ren Y; Liu Y; Zhang J; He JJ
    Oncol Res; 2017 Jan; 25(1):55-63. PubMed ID: 28081733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of FOXR2 inhibits non-small cell lung cancer cell proliferation and invasion through the Wnt/β-catenin signaling pathway.
    Wang XH; Cui YX; Wang ZM; Liu J
    Biochem Biophys Res Commun; 2018 Jun; 500(2):229-235. PubMed ID: 29634928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway.
    Si W; Li Y; Shao H; Hu R; Wang W; Zhang K; Yang Q
    Am J Med Sci; 2016 Aug; 352(2):191-9. PubMed ID: 27524218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RBMS3 Inhibits the Proliferation and Metastasis of Breast Cancer Cells.
    Yang Y; Quan L; Ling Y
    Oncol Res; 2018 Jan; 26(1):9-15. PubMed ID: 28409548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perichondrium mesenchymal stem cells inhibit the growth of breast cancer cells via the DKK-1/Wnt/β-catenin signaling pathway.
    Li M; Cai H; Yang Y; Zhang J; Sun K; Yan Y; Qu H; Wang W; Wang J; Duan X
    Oncol Rep; 2016 Aug; 36(2):936-44. PubMed ID: 27277008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LAPTM5 regulated by FOXP3 promotes the malignant phenotypes of breast cancer through activating the Wnt/β‑catenin pathway.
    Han S; Jin X; Hu T; Chi F
    Oncol Rep; 2023 Mar; 49(3):. PubMed ID: 36799186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors.
    Ahmad A; Wang Z; Kong D; Ali S; Li Y; Banerjee S; Ali R; Sarkar FH
    Breast Cancer Res Treat; 2010 Jul; 122(2):337-46. PubMed ID: 19813088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.